Gyre Therapeutics Inc. (GYRE)
undefined
undefined%
At close: undefined
10.30
6.19%
After-hours Dec 13, 2024, 05:53 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04
Net Income -85.48M -8.24M -87.93M -56.24M -55.18M -30.05M -21.56M -16.95M -14.76M -32.62M -46.70M -7.00M -8.53M 10.90M -39.40M -25.66M -28.07M 2.10M -28.99M -24.03M
Depreciation & Amortization 1.11M 230.00K 290.00K 138.00K 146.00K 149.00K 173.00K 389.00K 470.00K 351.00K 547.00K 2.21M 2.48M 2.00M 1.83M 1.80M 907.16K 820.92K 803.18K 766.34K
Stock-Based Compensation 7.28M 13.37M -283.18K 3.63M 3.20M 2.61M 863.00K 635.00K 326.00K 3.47M 5.22M 7.85M 8.51M 4.94M 2.45M 2.06M 2.75B 918.52M - -
Other Working Capital 4.22M 541.00K -5.39M -12.87M 20.67M -1.87M 650.00K 477.00K -1.91M -6.37M 2.74M -10.22M 10.35M - 17.23M -2.33M 49.27M -13.19M 1.59M -1.53M
Other Non-Cash Items 96.68M -21.48M 3.89M 1.05M 11.42M 116.00K 18.00K -3.39M 1.11M 613.00K -2.42M -56.98M -105.06M -86.85M -6.38M -6.30M 2.70M 515.87K 287.81K -259.88K
Deferred Income Tax -1.16M -838.00K -3.89M -1.05M -11.42M - - - -370.00K 72.00K 7.00K -101.00K - -3.09M 35.00K 220.00K - - - -
Change in Working Capital 7.46M -4.95M 483.00K -2.57M 8.21M -1.37M 567.00K 836.00K -6.26M -6.37M 2.74M -10.22M 10.35M 207.32M 17.23M -164.00K 49.30M -13.33M 1.65M -1.52M
Operating Cash Flow 25.89M -33.10M -83.75M -55.05M -43.61M -28.55M -19.94M -18.47M -19.12M -34.48M -40.61M -64.24M -83.72M 138.30M -24.27M -28.26M 24.84M -9.89M -26.25M -25.04M
Capital Expenditures -8.59M -5.00M -839.00K -267.00K -64.00K -376.00K -23.00K -468.00K -272.00K -4.00K -92.00K -333.00K -1.43M -3.31M -200.00K -2.05M -4.94M -1.08M -250.25K -660.62K
Acquisitions 4.02M 55.50M - -9.93M -27.46M - - 890.00K 23.93M - - - - - - - - - - -
Purchase of Investments -15.73M -50.51M - -97.64M -129.98M -198.91M -25.47M -13.40M - -7.17M -57.55M -120.97M -156.25M -144.01M -31.00M -104.80M -151.75M -41.19M -25.50M -6.19M
Sales Maturities Of Investments - 57.50M 49.03M 107.56M 157.43M 127.97M 14.30M 10.00M 13.82M 40.99M 69.88M 159.54M 100.01M 84.48M 41.00M 101.33M 130.41M 29.00M 25.50M 37.38M
Other Investing Acitivies 471.00K -2.06M 49.03M 9.93M 27.46M -70.94M -57.00K 2.56M -125.00K 38.00K 1.17M 1.59M 5.00K 43.00K - - - - - 38.19K
Investing Cash Flow -19.76M 55.43M 48.19M 9.66M 27.39M -71.32M -11.25M -1.31M 37.36M 33.86M 13.41M 39.82M -57.67M -62.80M 9.80M -5.52M -26.29M -13.27M -250.25K 30.56M
Debt Repayment - - - - - -5.08M -14.32M -10.00K 235.00K - -851.00K -1.24M 168.00K -349.00K -1.39M 2.19M 1.20M -783.89K -2.36M 2.52M
Common Stock Repurchased - - - - - - - - -82.00K - - - - - - - - - - -
Dividend Paid - -45.03M - - - - -3.95M - - - - - - - - - - - - -
Other Financial Acitivies 2.50M 20.00K - - - - 18.27M - 1.89M - - - - 3.50M - - - - - -
Financial Cash Flow 2.50M -45.01M 49.55M 60.38M 327.00K 111.33M 35.40M 948.00K 9.31M 5.01M -552.00K -626.00K 82.81M 6.45M 47.18M 31.58M 13.11M 40.05M -1.73M 35.94M
Net Cash Flow 8.33M -22.68M 13.99M 14.99M -15.89M 11.46M 4.21M -18.83M 27.55M 1.95M -27.75M -25.04M -58.57M 81.94M 32.71M -2.20M 11.66M 16.89M -28.22M 41.47M
Free Cash Flow 17.31M -38.09M -84.59M -55.31M -43.68M -28.93M -19.96M -18.94M -19.39M -34.49M -40.70M -64.57M -85.15M 134.99M -24.47M -30.31M 19.89M -10.97M -26.50M -25.70M